Compare
Merck & vs Supernus (MRK vs SUPN)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Merck & (MRK) returned +73.4% and Supernus (SUPN) -13.3%; so far this year the figures are +41.3% and -23.0%.
Merck & is the larger company by market value, about 227.8 times the size of Supernus.
Revenue grew +4.9% at MRK and +26.9% at SUPN over the last year.
MRK yields 2.29%. SUPN yields 29.44%.
Data as of the latest close. Not investment advice.
Relative performance
| MRK | SUPN | |
|---|---|---|
| Price | $148.76 | $27.62 |
| 1-day | +1.38% | +5.58% |
| YTD | +41.33% | -23.02% |
| 1 year | +73.42% | -13.34% |
| 3 years | +44.64% | +39.21% |
| Market cap | $366.7B | $1.6B |
| P/E | 151.8 | — |
| P/S | 5.44 | 1.86 |
| P/B | 8.17 | 1.51 |
| Revenue growth | +4.90% | +26.90% |
| EPS growth | -87.10% | — |
| Gross margin % | 71.8 | 87.6 |
| Net margin % | 3.6 | -5.1 |
| ROE % | 5.5 | -4.1 |
| Debt / equity | 1.20 | 0.38 |
| FCF yield % | 4.0 | 5.4 |
| Dividend yield % | 2.29 | 29.44 |
| Beta | 0.20 | 0.71 |
| RSI (14) | 54.1 | 30.6 |
| Technical rating |